Functional improvement and biological variations with sacubitril-valsartan and dapaglifozine prescription in the elderly with chronic heart failure. 350 patients, 85 and over, 3 years follow-up

S. Destrac, M. Cournot, M. Galinier

Open source

DOI
10.1016/j.acvdsp.2021.09.072
Published
2022-01
Container
Archives of Cardiovascular Diseases Supplements
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.acvdsp.2021.09.072,
  title = {Functional improvement and biological variations with sacubitril-valsartan and dapaglifozine prescription in the elderly with chronic heart failure. 350 patients, 85 and over, 3 years follow-up},
  author = {S. Destrac and M. Cournot and M. Galinier},
  year = {2022},
  journal = {Archives of Cardiovascular Diseases Supplements},
  doi = {10.1016/j.acvdsp.2021.09.072},
  url = {https://doi.org/10.1016/j.acvdsp.2021.09.072}
}

RIS

TY  - JOUR
TI  - Functional improvement and biological variations with sacubitril-valsartan and dapaglifozine prescription in the elderly with chronic heart failure. 350 patients, 85 and over, 3 years follow-up
AU  - S. Destrac
AU  - M. Cournot
AU  - M. Galinier
PY  - 2022
JO  - Archives of Cardiovascular Diseases Supplements
DO  - 10.1016/j.acvdsp.2021.09.072
UR  - https://doi.org/10.1016/j.acvdsp.2021.09.072
ER  - 

APA

Destrac, S., Cournot, M., & Galinier, M. (2022). Functional improvement and biological variations with sacubitril-valsartan and dapaglifozine prescription in the elderly with chronic heart failure. 350 patients, 85 and over, 3 years follow-up. Archives of Cardiovascular Diseases Supplements. https://doi.org/10.1016/j.acvdsp.2021.09.072

Source records